Sixty-two cases of squamous epitheliomata (47 males, 15 females) have attended the Dermatology Department in the last 10 years, and of these only 3 presented around the orbit. All were referred for radiotherapy. Squamous epitheliomata are uncommon, and I am sure that many so-called epitheliomata of my young days were actually kerato-acanthomata, benign tumours which we usually remove by curettage under local analgesia, although if left they will eventually drop off spontaneously within a period of 6 months.
I have never had referred to me a case of Bowen's disease (intra-epithelial epithelioma) arising in this situation.
True uncomplicated melanoma of the skin around the orbit must be very rare. Malignant change is said to occur in Ota's nevus but I have no experience of this. One patient referred for a melanoma of the lower eyelid was found to have a non-malignant mole after excision and biopsy. Pigmented basal papillomata, seborrhoeic warts and pigmented rodent ulcers may be mistaken for melanomata.
One of the most difficult problems is the lentigo maligna in the aged patient. Is one justified in excising a large lesion which may or may not undergo malignant change? On the whole biopsy does not help and I rely, perhaps wrongly, on clinical judgment.
Superficial lesions are usually treated by freezing for 8-10 seconds with CO2 snow which gives a good cosmetic result and long-term follow up is good. In the much blacker type, and particularly if there is heaping up of the surface, excision is the only treatment possible. Fortunately these seem to be much less invasively malignant than the ordinary malignant melanoma. One case of hmmangio-pericytoma seen responded well to radiotherapy.
Malignant disease arising elsewhere occasionally presents in this region. A patient with lymphatic leuk2emia with nodules around the eyelids and upper face was referred in the first instance to the skin department.
In conclusion, there is no rule-of-thumb method of therapy for these patients. The type of tumour, site, age and general condition of the patient must all be considered in deciding how the patient should be treated, and the decision is best taken by the team of radiotherapist, plastic surgeon and dermatologist consulting together, Radiotherapy has the following advantages in the treatment of skin cancer: it is a non-operative method, the cosmetic results in successful cases are excellent and it possesses economic advantages in that one X-ray apparatus can speedily treat an appreciable number of patients.
The special structure and function of the eyelids introduce certain problems in connexion with the treatment of neoplasms involving them. In surgical removal of a lid tumour a balance has to be struck between the amount of tissue removed and the need for reconstruction of any resulting defect. This balance is most often achieved by transgressing one of the most fundamental principles of cancer surgery, namely the need to remove all the tumour and a wide margin of apparently normal surrounding tissue. For this reason the incidence of incompletely removed lid tumours is distressingly high, so much so that most pathology departments have a shorthand term, ICR, they apply to these specimens, i.e. incompletely removed.
In contrast, the radiotherapist, whatever the size of the tumour, does not labour under these technical disadvantages, although in practice the post-radiation complication rate does tend to increase with the area of lid irradiated. The radiotherapist's ability to preserve the functional integrity of the lid is a further important advantage of radiotherapy.
In advocating the application of radiant energy in the neighbourhood of the eye, the risks of the method must be taken into account. The ease with which the eye can be damaged by radiation has been over-emphasized, largely because of the unfortunate accidents encountered by pioneer ophthalmologists. The normal eye will tolerate therapeutic doses of radiation well, provided sepsis and trauma are avoided. The following post-radiation sequelk may be encountered:
(1) Epilation of the lashes.
(2) Atrophy of the tarsal plates with lid deformity, either entropion or ectropion.
(3) Punctal obstruction, which is followed by a temporary epiphora. The reaction which results in blockage of the punctum also diminishes tear secretion by drying up the mucosal glands of the conjunctiva and lid in the treated area. After 6-9 months epiphora ceases to be a problem since the lack of drainage by the lower punctum is apparently counterbalanced by the reduction in the quantity of tears.
Section ofPlastic Surgery with Section ofDermatology and Section ofRadiology 691 (4) Keratinization of the mucosal surface of the lid may occur and if the mid-third of the upper lid is involved there is a risk of secondary damage to the cornea. When treating lid tumours the cornea can usually be protected from radiation damage. However, secondary corneal damage may occur: (a) by irritation from a keratinized lid, usually giving rise to an abrasion or a superficial punctate keratitis; (b) a vascular corneal opacity may develop when there is a deformity in the lid and exposure of the cornea; (c) filamentary keratitis may follow irradiation of the lacrimal apparatus, when the quality and quantity of the tears may be altered. The risk of these complications is usually predictable and often avoidable. (5) Secondary glaucoma, cataract, and other intraocular complications may occur when radioactive sources are used near the eye and when ocular protection is impractical.
The risk of complications can be reduced by avoiding the use of radioactive implants near the eye whenever possible, by avoiding high dosage and short treatment times and repeated courses of treatment, and by recognizing certain contraindications to radiation treatment: (1) Recurrent cases, which should be surgically treated wherever possible. The retreatment by further radiation of a radiation recurrence always causes a risk of tissue damage and a lessened chance of a successful result. (2) When the disease involves the midthird of the upper lid cure by radiation is possible, but post-radiation mucosal changes in this region may well produce secondary damage to the closely related cornea. (3) If the lid lesion is associated with an abnormal cornea, then any subsequent post-radiation changes in the lid may produce further corneal change. In the last two circumstances, if there is no alternative to radiation, the risks ofcomplications following the post-radiation lid changes can be largely overcome by the use of a contact lens.
Mr Robin L B Beare (London)
Basal Cell Carcinoma' One of the commonest reasons for undertaking total exenteration of the orbit is that the globe of the eye has been invaded by a malignant epithelial tumour arising in the palpebral or canthal skin. The fact that the majority of these tumours are of low-grade malignancy, being basal cell carcinomata, and that the invaded eye, in the absence of 'Presidential Address: Section of Plastic Surgery. Requests for reprints to 149 Harley Street, London Wl previous irradiation damage, has normal vision, merely emphasizes the tragedy of exenteration and raises the question as to how this monstrous and distressing operation might have been avoided.
It is intended, therefore, to examine the behaviour of these tumours of the orbital region from a surgeon's point-of-view, and to discuss the factors which may guide the clinician in his choice between surgical excision, irradiation or, occasionally, superficial destruction by physical oI chemical means, for the treatment of a particular rodent ulcer of the orbital region. It is not proposed to quote figures which might extoll the advantages of any particular method but rather to give voice to some observations which I have made in treating over 1000 cases of this disease.
Types ofTumour
The single pathological description, basal cell carcinoma, embraces a number of different clinical entities, which are easily recognized and whose appearance and behaviour are so different as to suggest that two or three separate diseases are involved. Thus, as clinicians, we are all familiar with cystic rodent ulcer, the morphoeic rodent ulcer, the 'typical rodent ulcer' and the deeply invasive rodent ulcer. The pigmented rodent ulcer and the Bowen type are further examples. These clinical appearances do not, however, apart from the cystic variety, coincide with any observable histological features and the pathologist recognizes them all as basal cell carcinomata, his variations being the cystic type (which contains cysts), the multicentric type, and the occasional basi-squamous tumour. This indicates that anaplasia and other variations in the degree of differentiation do not occur and cannot, therefore, be used, as with other malignant tumours, as a guide to invasive potential nor to radiosensitivity.
The invasive tendency of these tumours varies as much as their clinical appearance. The large protuberant, cystic or solid type is so non-invasive from a surgical point-of-view that it can almost be regarded as benign. At the other extreme is the aggressive penetrating tumour which is relatively uncommon as a primary untreated lesion but a form which basal cell carcinoma may take if it recurs after irradiation. In this form the disease spreads with great rapidity and may lead to the death of the patient unless its extreme local malignancy is appreciated at an early stage.
Between these two extremes lie the majority of basal cell carcinomata. Invasion is slow, but steady, and tends to take place peripherally rather than in depth. Certain tissue layers, e.g. the orbital septum or temporal fascia, are seldom penetrated by untreated tumours, and act as
